Read More Pharma Industry News Antengene receives approval for ATG-016 clinical trial in myelodysplastic syndrome Antengene, a leading Chinese biopharmaceutical company, has announced a significant milestone with the approval of its Phase 1/2… bypharmanewsdailyNovember 26, 2020